Nutex Health (NUTX) Cash from Investing Activities (2016 - 2026)
Nutex Health (NUTX) has disclosed Cash from Investing Activities for 17 consecutive years, with -$1.2 million as the latest value for Q1 2026.
- For Q1 2026, Cash from Investing Activities fell 1776.56% year-over-year to -$1.2 million; the TTM value through Mar 2026 reached -$6.4 million, down 29.21%, while the annual FY2025 figure was -$5.2 million, 6.49% up from the prior year.
- Cash from Investing Activities hit -$1.2 million in Q1 2026 for Nutex Health, up from -$5.1 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $7.9 million in Q4 2022 and bottomed at -$8.6 million in Q1 2022.
- Average Cash from Investing Activities over 5 years is -$1.6 million, with a median of -$1.2 million recorded in 2026.
- Year-over-year, Cash from Investing Activities skyrocketed 166.95% in 2022 and then crashed 1776.56% in 2026.
- Nutex Health's Cash from Investing Activities stood at $7.9 million in 2022, then crashed by 89.02% to $865481.0 in 2023, then tumbled by 485.45% to -$3.3 million in 2024, then tumbled by 52.04% to -$5.1 million in 2025, then surged by 76.32% to -$1.2 million in 2026.
- According to Business Quant data, Cash from Investing Activities over the past three periods came in at -$1.2 million, -$5.1 million, and -$302000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.